Edeniq, Inc., has announced the receipt of notice of allowance from the U.S. Patent and Trademark Office for the patent, “Materials and Methods for Converting Biomass to Biofuel.” The patent covers certain core equipment and process technology used in Edeniq’s Cellunator offering, Pathway integrated platform, and continuous cellulosic sugar production process. Cellunator increases ethanol yield by two to four percent by optimizing starch conversion. The Pathway platform combines the Cellunator technology with an enzyme cocktail to break down corn kernel fiber, releasing cellulosic sugars into the fermentation process.- Don’t miss out on the F.O. Licht’s Ethanol Latin America 2013, being held December 2-4, 2013 in Cali, Columbia. Attendees will receive a free copy of F.O. Lichts Sugar & Ethanol 2014 report. In addition to the conference, there is a pre-conference ethanol technology production day where attendees will visit an ethanol plant followed by a production efficiency workshop. Click here for more information and to register.
- BlueFire Renewables has integrated a synergistic wood pellet production plant to its facility in Fulton, Mississippi. The reconfigured design will be a 9 million gallon per year ethanol plant integrated with a 400,000 ton per year wood pellet plant. The pellets will be sold under long term contracts into the European mandated renewable energy market.
- Intermolecular and RUSNANO, the Fund for Infrastructure and Educational Programs, has announced the signing of a joint development agreement between Intermolecular and Ulnanotech, the leading Russian Federation nanocenter based in Ulyanovsk. Ulnanotech will leverage leading-edge development platforms purchased from Intermolecular to accelerate research and development (R&D) efforts around glass coatings, advanced power electronics, photovoltaics and displays. In addition to providing advanced development platforms to Ulnanotech, Silicon Valley-based Intermolecular will assist the company in developing and executing new business opportunities and programs. Intermolecular will share in potential future profits from service and licensing revenue associated with those activities.
